The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer
Open accessAbstract
Abstract To stratify the heterogeneity of prostate cancer (PCa) with seminal vesicle invasion (SVI) immunologically after radical prostatectomy focusing on the tumor microenvironment. We retrospectively reviewed the clinicopathological data of 71 PCa patients with SVI, which is known as a factor of very high-risk PCa. Preoperative clinical variables and postoperative pathological variables were evaluated as predictors of biochemical recurrence (BCR) with a multivariate logistic regression. Immune cell infiltration including the CD8-positive cell (CD8+ cell) and CD204-positive M2-like macrophage (CD204+ cell) was investigated by immunohistochemistry. The cumulative incidence and risk of BCR were assessed with a Kaplan–Meier analysis and competing risks regression. A higher CD8+ cell count in the SVI area significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). A lower CD204+ cell count in the SVI area also significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). Furthermore, the combination of the CD8+ and CD204+ cell infiltration ratio of the SVI area to the main tumor area was a significant factor for BCR in the patients with the PCa with SVI (p = 0.001). In PCa patients with SVI, the combination of CD8+ and CD204+ cell infiltration is useful to predict the prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, mast cells contribute to increased chemotherapy and radiotherapy resistance (Xie et al., 2016), while tumor infiltrating CD8+ T cells are–similar to ovarian cancers or other ‘hot’ tumors–associated with improved clinical outcome (Yanai et al., 2021; Yang et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Yanai et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
Cookson, M. S., Aus, G., Burnett, A. L., Canby-Hagino, E. D., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., Goldenberg, S. L., Hernandez, J., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.10.097 · Cited by 844
Spranger, S., Koblish, H. K., Horton, B., Scherle, P. A., Newton, R., & Gajewski, T. F. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-3 · Cited by 552
Wiegel, T., Bartkowiak, D., Bottke, D., Bronner, C., Steiner, U., Siegmann, A., Golz, R., Störkel, S., Willich, N., Semjonow, A., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.03.011 · Cited by 440
Becht, E., Giraldo, N. A., Germain, C., de Reyniès, A., Laurent-Puig, P., Zucman-Rossi, J., Dieu-Nosjean, M.-C., Sautès-Fridman, C., & Fridman, W. H. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2015.12.002 · Cited by 213
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Leclerc, B. G., Charlebois, R., Chouinard, G., Allard, B., Pommey, S., Saad, F., & Stagg, J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1181 · Cited by 200
High Oct4 expression: implications in the pathogenesis of neuroblastic tumours
Monferrer, E., Burgos-Panadero, R., Blanquer-Maceiras, M., Cañete, A., Navarro, S., & Noguera, R. (2019) · BMC Cancer · doi:10.1186/s12885-018-5219-3 · Cited by 196
Cited by
The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer
Gudgeon, J., Marín‐Rubio, J. L., & Trost, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012002 · Cited by 137
Hansen, S. B., Unal, B., Kuzu, O. F., & Saatcioglu, F. (2024) · Theranostics · doi:10.7150/thno.100555 · Cited by 45
“…task, however, as some studies associate high numbers of CTLs with increased time to biochemical recurrence and overall survival after surgery [70, 73], while others find a shorter time to cancer progression with high cell density [74, 75], suggesting a context dependency the basis of which is…”
BackgroundDietary fat and lipid metabolism in the tumor microenvironment
Goswami, S., Zhang, Q., Celik, C. E., Reich, E. M., & Yilmaz, Ö. H. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188984 · Cited by 41
Macrophage scavenger receptors: Tumor support and tumor inhibition
Kazakova, E., Iamshchikov, P. S., Larionova, I., & Kzhyshkowska, J. G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1096897 · Cited by 34
Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
dos Reis, F. D., Jerónimo, C., & Correia, M. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152572 · Cited by 17
“While a high CD8 TIL density in PCa has been independently associated with improved OS, PCa‐specific survival (41, 42) and longer time to biochemical recurrence in patients with seminal vesicle invasion (43), other studies have found an association between high CD8 T cell density, worse clinical progression and PCa ma…”
Result
Metadata
- Authors
- Yanai, Y., Kosaka, T., Mikami, S., Hongo, H., Yasumizu, Y., Takeda, T., Matsumoto, K., Miyauchi, J., Kitano, S., & Oya, M.
- Affiliations
- Keio University (JP)
- Saitama Municipal Hospital (JP)
- National Cancer Center Hospital (JP)
- Corresponding author
- Kosaka, Takeo
- ORCID
- Venue
- Scientific Reports
- Published
- 2021-11-18
- Volume
- 11
- Issue
- 1
- Pages
- 22495-22495
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC8602636
- OpenAlex
- W3182507454
- Cited by
- 28
- References
- 30
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 8 · 2023: 4 · 2022: 6
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Grants-in-Aid for Scientific Research (#18K16709, #17K11158)
- Takeda Science Foundation
- Japan from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from SGH foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- prostate cancer, seminal vesicle invasion, CD8+ T cells, CD204, M2 macrophages, tumor microenvironment, radical prostatectomy, biochemical recurrence, prognostic factors, immune cell infiltration, very high-risk prostate cancer
- MeSH terms
- Aged, Humans, Macrophages, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Prostate, Prostatectomy, Prostatic Neoplasms, Regression Analysis, Retrospective Studies, Risk, Seminal Vesicles, Incidence, Multivariate Analysis, Prostate-Specific Antigen, CD8-Positive T-Lymphocytes, Scavenger Receptors, Class A, Kaplan-Meier Estimate, Tumor Microenvironment, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer. https://app.cochat.ai/papers/10.1038/s41598-021-01900-4
- The paper
- Yanai, Y., Kosaka, T., Mikami, S., Hongo, H., Yasumizu, Y., Takeda, T., Matsumoto, K., Miyauchi, J., Kitano, S., & Oya, M. (2021). CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer. Scientific Reports. https://doi.org/10.1038/s41598-021-01900-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.